Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
Resource Type
Article
Authors
Winer, Eric P ; Lipatov, Oleg ; Im, Seock-Ah ; Goncalves, Anthony ; Muñoz-Couselo, Eva ; Lee, Keun Seok ; Schmid, Peter ; Tamura, Kenji ; Testa, Laura ; Witzel, Isabell ; Ohtani, Shoichiro ; Turner, Nicholas ; Zambelli, Stefania ; Harbeck, Nadia ; Andre, Fabrice ; Dent, Rebecca ; Zhou, Xuan ; Karantza, Vassiliki ; Mejia, Jaime ; Cortes, Javier
Source
In The Lancet Oncology April 2021 22(4):499-511
Subject
Primary Research Articles
Language
ISSN
1470-2045